Chemical Translational Biology: Redefining Druggability of Protein-Protein Interactions

被引:1
作者
Cesa, Laura C. [1 ]
机构
[1] Univ Copenhagen, Ctr Biopharmaceut, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark
关键词
allostery; chemical biology; drug discovery; protein-protein interactions; INHIBITORS; DISCOVERY; IDENTIFICATION; ACTIVATION; PPIS;
D O I
10.1002/cbic.202000532
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemical biologists use chemical tools to answer biological questions. The translational application of these principles has led to an explosion in the discovery and druggability of new protein targets, including protein-protein interactions (PPIs). Proteins tend to interact with other macromolecules using relatively large and featureless binding surfaces, which has hampered traditional drug discovery efforts, particularly for interactions with weaker affinity. In this article, I discuss several emerging strategies for targeting PPIs, including computational and structural methods and novel screening approaches. In particular, I focus on hijacking intrinsic protein allosteric pathways for the discovery and design of small-molecule and peptide ligands.
引用
收藏
页码:985 / 987
页数:3
相关论文
共 50 条
  • [21] Drug discovery by targeting the protein-protein interactions involved in autophagy
    Xiang, Honggang
    Zhou, Mi
    Li, Yan
    Zhou, Lu
    Wang, Renxiao
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (11) : 4373 - 4390
  • [22] Flexibility and small pockets at protein-protein interfaces: New insights into druggability
    Jubb, Harry
    Blundell, Tom L.
    Ascher, David B.
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2015, 119 (01) : 2 - 9
  • [23] Probing the druggability of protein-protein interactions: targeting the Notch1 receptor ankyrin domain using a fragment-based approach
    Abdel-Rahman, Noha
    Martinez-Arias, Alfonso
    Blundell, Tom L.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 1327 - 1333
  • [24] Interfacial Peptides as Affinity Modulating Agents of Protein-Protein Interactions
    Ershov, Pavel V.
    Mezentsev, Yuri V.
    Ivanov, Alexis S.
    BIOMOLECULES, 2022, 12 (01)
  • [25] High-Throughput Chemical Probing of Full-Length Protein-Protein Interactions
    Song, James M.
    Menon, Arya
    Mitchell, Dylan C.
    Johnson, Oleta T.
    Garner, Amanda L.
    ACS COMBINATORIAL SCIENCE, 2017, 19 (12) : 763 - 769
  • [26] Targeting protein-protein interactions for cancer therapy
    Fry, DC
    Vassilev, LT
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (12): : 955 - 963
  • [27] Targeting Protein-Protein Interactions in Hematologic Malignancies
    Cierpicki, Tomasz
    Grembecka, Jolanta
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2025, 20 : 275 - 301
  • [28] Stabilization of protein-protein interactions in drug discovery
    Andrei, Sebastian A.
    Sijbesma, Eline
    Hann, Michael
    Davis, Jeremy
    O'Mahony, Gavin
    Perry, Matthew W. D.
    Karawajczyk, Anna
    Eickhoff, Jan
    Brunsveld, Luc
    Doveston, Richard G.
    Milroy, Lech-Gustav
    Ottmann, Christian
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (09) : 925 - 940
  • [29] Targeting Protein-Protein Interactions in the HIF System
    Wilkins, Sarah E.
    Abboud, Martine I.
    Hancock, Rebecca L.
    Schofield, Christopher J.
    CHEMMEDCHEM, 2016, 11 (08) : 773 - 786
  • [30] Cold spots are universal in protein-protein interactions
    Gurusinghe, Sagara N. S.
    Oppenheimer, Ben
    Shifman, Julia M.
    PROTEIN SCIENCE, 2022, 31 (10)